Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/3082
標題: 嗜酸乳桿菌胞外多醣體醱酵製程、純化與結構鑑定
Fermentation Process, Purification and Identification of Extracellular Polysaccharides from Lactobacillus acidophilus
作者: 黃嘉駿
Huang, Jia-Jun
關鍵字: 嗜酸乳桿菌
Lactobacillus acidophilus
胞外多醣體醱酵程序
反應曲面法
多醣體純化
多醣體結構鑑定
Extracellular polysaccharide of fermentation process
Response surface methodology
Purification of polysaccharide
Identification of polysaccharide
出版社: 化學工程學系所
引用: Afrc, R.F. 1989. Probiotics in man and animals. Journal of Applied Microbiology, 66(5), 365-378. Ahn, Y.T., Kim, G.B., Lim, K.S., Baek, Y.J., Kim, H.U. 2003. Deconjugation of bile salts by Lactobacillus acidophilus isolates. International Dairy Journal, 13(4), 303-311. Amalaradjou, M.A.R., Bhunia, A.K. 2012. Chapter Five - Modern Approaches in Probiotics Research to Control Foodborne Pathogens. in: Advances in Food and Nutrition Research, (Ed.) H. Jeyakumar, Vol. Volume 67, Academic Press, pp. 185-239. Badel, S., Bernardi, T., Michaud, P. 2011. New perspectives for Lactobacilli exopolysaccharides. Biotechnology Advances, 29(1), 54-66. Beachey, E.H. 1981. Bacterial adherence: Adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. Journal of Infectious Diseases, 143(3), 325-345. Bomba, A., Kravjansky, I., Kaštel, R., Herich, R., Juhasova, Z., Čižek, M., Kapitančik, B. 1997. Inhibitory effects of Lactobacillus casei upon the adhesion of enterotoxigenic Escherichia coli K99 to the intestinal mucosa in gnotobiotic lambs. Small Ruminant Research, 23(2–3), 199-206. Bottomley, P.A. 1982. NMR imaging techniques and applications: a review. Review of Scientific Instruments, 53(9), 1319-1337. Bouzar, F., Cerning, J., Desmazeaud, M. 1996. Exopolysaccharide Production in Milk by Lactobacillus delbrueckii ssp. bulgaricus CNRZ 1187 and by Two Colonial Variants. Journal of Dairy Science, 79(2), 205-211. British Pharmacopoeia. 2012a. Appendix XV G. Composition of Polysaccharide Vaccines. British Pharmacopoeia. British Pharmacopoeia. 2012b. Meningococcal Polysaccharide Vaccine. British Pharmacopoeia. Bruce, A.W., Reid, G. 1988. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Canadian Journal of Microbiology, 34(3), 339-343. Burton, J.P., Tannock, G.W. 1997. Properties of Porcine and Yogurt Lactobacilli in Relation to Lactose Intolerance. Journal of Dairy Science, 80(10), 2318-2324. Carasi, P., Trejo, F.M., Perez, P.F., De Antoni, G.L., Serradell, M.d.l.A. 2012. Surface proteins from Lactobacillus kefir antagonize in vitro cytotoxic effect of Clostridium difficile toxins. Anaerobe, 18(1), 135-142. Cerning, J. 1990. Exocellular polysaccharides produced by lactic acid bacteria. FEMS Microbiology Letters, 87(1-2), 113-130. Cerning, J., Bouillanne, C., Landon, M., Desmazeaud, M. 1992. Isolation and Characterization of Exopolysaccharides from Slime-Forming Mesophilic Lactic Acid Bacteria. Journal of Dairy Science, 75(3), 692-699. Chan, R.C.Y., Reid, G., Irvin, R.T., Bruce, A.W., Costerton, J.W. 1985. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infection and Immunity, 47(1), 84-89. Chaveerach, P., Lipman, L.J.A., van Knapen, F. 2004. Antagonistic activities of several bacteria on in vitro growth of 10 strains of Campylobacter jejuni/coli. International Journal of Food Microbiology, 90(1), 43-50. Chen, X., Xu, J., Shuai, J., Chen, J., Zhang, Z., Fang, W. 2007. The S-layer proteins of Lactobacillus crispatus strain ZJ001 is responsible for competitive exclusion against Escherichia coli O157:H7 and Salmonella typhimurium. International Journal of Food Microbiology, 115(3), 307-312. Ciucanu, I., Kerek, F. 1984. A simple and rapid method for the permethylation of carbohydrates. Carbohydrate Research, 131(2), 209-217. Collado, M.C., Hernandez, M., Sanz, Y. 2005. Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains. Journal of Food Protection, 68(5), 1034-1040. Collado, M.C., Meriluoto, J., Salminen, S. 2007. In vitro analysis of probiotic strain combinations to inhibit pathogen adhesion to human intestinal mucus. Food Research International, 40(5), 629-636. Collins, J.K., Thornton, G., Sullivan, G.O. 1998. Selection of Probiotic Strains for Human Applications. International Dairy Journal, 8(5–6), 487-490. Coman, M.M., Cecchini, C., Verdenelli, M.C., Silvi, S., Orpianesi, C., Cresci, A. 2012. Functional foods as carriers for SYNBIOR, a probiotic bacteria combination. International Journal of Food Microbiology, 157(3), 346-352. Conway, P.L. 1996. Selection criteria for probiotic microorganisms. Asia pacific Journal of clinical Nutrition, 5, 10-14. Corzo, G., Gilliland, S.E. 1999. Measurement of bile salt hydrolase activity from Lactobacillus acidophilus based on disappearance of conjugated bile salts. Journal of Dairy Science, 82(3), 466-471. Cui, S.W. 2005. Food carbohydrates: chemistry, physical properties, and applications. Taylor & Francis Boca Raton, FL. De Man, J.C., Rogosa, M., Sharpe, M.E. 1960. A medium for the cultivation of Lactobacilli. Journal of Applied Microbiology, 23(1), 130-135. de Moreno de LeBlanc, A., Castillo, N.A., Perdigon, G. 2010. Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection. International Journal of Food Microbiology, 138(3), 223-231. De Vuyst, L., De Vin, F., Vaningelgem, F., Degeest, B. 2001. Recent developments in the biosynthesis and applications of heteropolysaccharides from lactic acid bacteria. International Dairy Journal, 11(9), 687-707. Doddrell, D., Pegg, D., Bendall, M.R. 1982. Distortionless enhancement of NMR signals by polarization transfer. Journal of Magnetic Resonance (1969), 48(2), 323-327. Esvaran, M., Conway, P.L. 2012. Strain dependent protection conferred by Lactobacillus spp. administered orally with a Salmonella Typhimurium vaccine in a murine challenge model. Vaccine, 30(16), 2654-2661. Femia, A.P., Luceri, C., Dolara, P., Giannini, A., Biggeri, A., Salvadori, M., Clune, Y., Collins, K.J., Paglierani, M., Caderni, G. 2002. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis, 23(11), 1953-1960. Fichera, G.A., Giese, G. 1994. Non-immunologically-mediated cytotoxicity of Lactobacillus casei and its derivative peptidoglycan against tumor cell lines. Cancer Letters, 85(1), 93-103. Fooks, L.J., Fuller, R., Gibson, G.R. 1999. Prebiotics, probiotics and human gut microbiology. International Dairy Journal, 9(1), 53-61. Freter, R. 1992. Factors affecting the microecology of the gut. in: Probiotics, Springer Netherlands, pp. 111-144. Ganzle, M.G., Hertel, C., van der Vossen, J.M.B.M., Hammes, W.P. 1999. Effect of bacteriocin-producing lactobacilli on the survival of Escherichia coli and Listeria in a dynamic model of the stomach and the small intestine. International Journal of Food Microbiology, 48(1), 21-35. Gilliland, S., Nelson, C., Maxwell, C. 1985. Assimilation of cholesterol by Lactobacillus acidophilus. Applied and Environmental Microbiology, 49(2), 377-381. Gilliland, S.E., Kim, H.S. 1984. Effect of Viable Starter Culture Bacteria in Yogurt on Lactose Utilization in Humans. Journal of Dairy Science, 67(1), 1-6. Graul, T., Cain, A.M., Karpa, K.D. 2009. Lactobacillus and bifidobacteria combinations: A strategy to reduce hospital-acquired Clostridium difficile diarrhea incidence and mortality. Medical Hypotheses, 73(2), 194-198. Grobben, G.J., Smith, M.R., Sikkema, J., de Bont, J.A.M. 1996. Influence of fructose and glucose on the production of exopolysaccharides and the activities of enzymes involved in the sugar metabolism and the synthesis of sugar nucleotides in Lactobacillus delbrueckii subsp. bulgaricus NCFB 2772. Applied Microbiology and Biotechnology, 46(3), 279-284. Gueimonde, M., Salminen, S. 2006. New methods for selecting and evaluating probiotics. Digestive and Liver Disease, 38, Supplement 2(0), S242-S247. Hamilton-Miller, J., Gibson, G., Bruck, W. 2003. Letter to the Editor Some insights into the derivation and early uses of the word ‘probiotic’. British Journal of Nutrition, 90(845). Horinaka, M., Yoshida, T., Kishi, A., Akatani, K., Yasuda, T., Kouhara, J., Wakada, M., Sakai, T. 2010. Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells. FEBS Letters, 584(3), 577-582. HotWire, R. December 2011. Box-Behnken Designs for Optimizing Product Performance. Huis in''t Veld, J.H.J., Havenaar, R., Marteau, P. 1994. Establishing a scientific basis for probiotic R&D. Trends in Biotechnology, 12(1), 6-8. Ibarra, A., Acha, R., Calleja, M.T., Chiralt-Boix, A., Wittig, E. 2012. Optimization and shelf life of a low-lactose yogurt with Lactobacillus rhamnosus HN001. Journal of Dairy Science, 95(7), 3536-3548. Jara, S., Sanchez, M., Vera, R., Cofre, J., Castro, E. 2011. The inhibitory activity of Lactobacillus spp. isolated from breast milk on gastrointestinal pathogenic bacteria of nosocomial origin. Anaerobe, 17(6), 474-477. Juntunen, M., Kirjavainen, P., Ouwehand, A., Salminen, S., Isolauri, E. 2001a. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clinical and diagnostic laboratory immunology, 8(2), 293-296. Juntunen, M., Kirjavainen, P.V., Ouwehand, A.C., Salminen, S.J., Isolauri, E. 2001b. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clinical and Diagnostic Laboratory Immunology, 8(2), 293-296. Kajander, K., Hatakka, K., Poussa, T., Farkkila, M., Korpela, R. 2005. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention. Alimentary Pharmacology and Therapeutics, 22(5), 387-394. Kandasamy, M., Bay, B.-H., Lee, Y.-K., Mahendran, R. 2011. Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells. Cellular Immunology, 271(1), 89-96. Kenny, O., FitzGerald, R.J., O’Cuinn, G., Beresford, T., Jordan, K. 2006. Autolysis of selected Lactobacillus helveticus adjunct strains during Cheddar cheese ripening. International Dairy Journal, 16(7), 797-804. Kimmel, S.A., Roberts, R.F. 1998. Development of a growth medium suitable for exopolysaccharide production by Lactobacillus delbrueckii ssp. bulgaricus RR. International Journal of Food Microbiology, 40(1–2), 87-92. Kumar, C.G., Anand, S.K. 1998. Significance of microbial biofilms in food industry: a review. International Journal of Food Microbiology, 42(1–2), 9-27. Lee, Y.-J., Yu, W.-K., Heo, T.-R. 2003. Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces. International Journal of Antimicrobial Agents, 21(4), 340-346. Lee, Y.-K., Salminen, S. 1995. The coming of age of probiotics. Trends in Food Science & Technology, 6(7), 241-245. Lehto, E.M., Salminen, S.J. 1997. Inhibition of Salmonella typhimurium adhesion to Caco-2 cell cultures by Lactobacillus strain GG spent culture supernate: only a pH effect? FEMS Immunology and Medical Microbiology, 18(2), 125-132. Li, P., Yin, Y., Yu, Q., Yang, Q. 2011. Lactobacillus acidophilus S-layer protein-mediated inhibition of Salmonella-induced apoptosis in Caco-2 cells. Biochemical and Biophysical Research Communications, 409(1), 142-147. Lilly, D.M., Stillwell, R.H. 1965. Probiotics: growth-promoting factors produced by microorganisms. Science, 147(3659), 747-748. Lin, C.-K., Tsai, H.-C., Lin, P.-P., Tsen, H.-Y., Tsai, C.-C. 2008. Lactobacillus acidophilus LAP5 able to inhibit the Salmonella choleraesuis invasion to the human Caco-2 epithelial cell. Anaerobe, 14(5), 251-255. Lin, P.-P., Hsieh, Y.-M., Tsai, C.-C. 2009. Antagonistic activity of Lactobacillus acidophilus RY2 isolated from healthy infancy feces on the growth and adhesion characteristics of enteroaggregative Escherichia coli. Anaerobe, 15(4), 122-126. Liong, M.T., Shah, N.P. 2005. Acid and Bile Tolerance and Cholesterol Removal Ability of Lactobacilli Strains. Journal of Dairy Science, 88(1), 55-66. Liu, X., Liu, W., Zhang, Q., Tian, F., Wang, G., Zhang, H., Chen, W. 2013. Screening of lactobacilli with antagonistic activity against enteroinvasive Escherichia coli. Food Control, 30(2), 563-568. Looijesteijn, P.J., Trapet, L., de Vries, E., Abee, T., Hugenholtz, J. 2001. Physiological function of exopolysaccharides produced by Lactococcus lactis. International Journal of Food Microbiology, 64(1–2), 71-80. Lye, H.-S., Alias, K.A., Rusul, G., Liong, M.-T. 2012. Ultrasound treatment enhances cholesterol removal ability of lactobacilli. Ultrasonics Sonochemistry, 19(3), 632-641. Manson, J.E., Tosteson, H., Ridker, P.M., Satterfield, S., Hebert, P., O''Connor, G.T., Buring, J.E., Hennekens, C.H. 1992. Medical progress: The primary prevention of myocardial infarction. New England Journal of Medicine, 326(21), 1406-1416. Marshall, V.M., Cowie, E.N., Moreton, R.S. 1995. Analysis and production of two exopolysaccharides from Lactococcus lactis subsp. cremoris LC330. Journal of Dairy Research, 62(04), 621-628. McBean, L.D., Miller, G.D. 1998. Allaying Fears and Fallacies about Lactose Intolerance. Journal of the American Dietetic Association, 98(6), 671-676. Messaoudi, S., Kergourlay, G., Dalgalarrondo, M., Choiset, Y., Ferchichi, M., Prevost, H., Pilet, M.-F., Chobert, J.-M., Manai, M., Dousset, X. 2012. Purification and characterization of a new bacteriocin active against Campylobacter produced by Lactobacillus salivarius SMXD51. Food Microbiology, 32(1), 129-134. Metchnikoff, E., Metchnikoff, I.I., Mitchell, P.C. 2004. The prolongation of life: optimistic studies. Springer Publishing Company. Meydani, S.N., Ha, W.-K. 2000. Immunologic effects of yogurt. The American Journal of Clinical Nutrition, 71(4), 861-872. Miller, M. 2009. The fascination with probiotics for Clostridium difficile infection: Lack of evidence for prophylactic or therapeutic efficacy. Anaerobe, 15(6), 281-284. Moorthy, G., Murali, M.R., Devaraj, S.N. 2009. Lactobacilli facilitate maintenance of intestinal membrane integrity during Shigella dysenteriae 1 infection in rats. Nutrition, 25(3), 350-358. Moorthy, G., Murali, M.R., Niranjali Devaraj, S. 2010. Lactobacilli inhibit Shigella dysenteriae 1 induced pro-inflammatory response and cytotoxicity in host cells via impediment of Shigella–host interactions. Digestive and Liver Disease, 42(1), 33-39. Moyen, E.N., Bonneville, F., Fauchere, J.L. 1986. Modification parlerythromycine et un extrait de Lactobacillus acidophilus de la colonisation de l''intestin et de la translocation de Campylobacter jejuni chez la souris axenique. Annales de l''Institut Pasteur / Microbiologie, 137(1, Supplement A), 199-207. Myllyluoma, E., Veijola, L., Ahlroos, T., Tynkkynen, S., Kankuri, E., Vapaatalo, H., Rautelin, H., Korpela, R. 2005. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - A placebo-controlled, double-blind randomized pilot study. Alimentary Pharmacology and Therapeutics, 21(10), 1263-1272. Nemcova, R., Borovska, D., Koščova, J., Gancarčikova, S., Mudroňova, D., Buleca, V., Pistl, J. 2012. The effect of supplementation of flax-seed oil on interaction of Lactobacillus plantarum – Biocenol™ LP96 and Escherichia coli O8:K88ab:H9 in the gut of germ-free piglets. Research in Veterinary Science, 93(1), 39-41. O''Neil, D.A., Porter, E.M., Elewaut, D., Anderson, G.M., Eckmann, L., Ganz, T., Kagnoff, M.F. 1999. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. Journal of Immunology, 163(12), 6718-6724. Organization, F.a.A.O.o.t.U.N.W.H. October 2001. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Paolillo, R., Romano Carratelli, C., Sorrentino, S., Mazzola, N., Rizzo, A. 2009. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. International Immunopharmacology, 9(11), 1265-1271. Parassol, N., Freitas, M., Thoreux, K., Dalmasso, G., Bourdet-Sicard, R., Rampal, P. 2005. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Research in Microbiology, 156(2), 256-262. Parker, R.B. 1974. Probiotics, the other half of the antibiotic story. Animal Nutrition and Health, 29, 4-8. Pieper, R., Janczyk, P., Urubschurov, V., Hou, Z., Korn, U., Pieper, B., Souffrant, W.B. 2010. Effect of Lactobacillus plantarum on intestinal microbial community composition and response to enterotoxigenic Escherichia coli challenge in weaning piglets. Livestock Science, 133(1–3), 98-100. Preston, C.M. 1996. Applications of NMR to soil organic matter analysis: history and prospects. Soil Science, 161(3), 144-166. Reid, G., Chan, R.C.Y., Bruce, A.W., Costerton, J.W. 1985. Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain. Infection and Immunity, 49(2), 320-324. Reid, G., Cook, R.L., Bruce, A.W. 1987. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. Journal of Urology, 138(2), 330-335. Ringo, E., Gatesoupe, F.-J. 1998. Lactic acid bacteria in fish: a review. Aquaculture, 160(3–4), 177-203. Roberts, I.S. 1996. The biochemistry and genetics of capsular polysaccharide production in bacteria, Vol. 50, pp. 285-315. Roselli, M., Finamore, A., Britti, M.S., Mengheri, E. 2006. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. British Journal of Nutrition, 95(6), 1177-1184. Ruas-Madiedo, P., de los Reyes-Gavilan, C.G. 2005. Invited Review: Methods for the Screening, Isolation, and Characterization of Exopolysaccharides Produced by Lactic Acid Bacteria. Journal of Dairy Science, 88(3), 843-856. Rusch, V. 2002. Probiotics and definitions: a short overview. Herborn Litterae. Salminen, S., Bouley, C., Boutron-Ruault, M., Cummings, J., Franck, A., Gibson, G., Isolauri, E., Moreau, M., Roberfroid, M., Rowland, I. 1998. Functional food science and gastrointestinal physiology and function. British Journal of Nutrition, 80(1), S147. Salminen, S., Ouwehand, A., Benno, Y., Lee, Y.K. 1999. Probiotics: How should they be defined? Trends in Food Science and Technology, 10(3), 107-110. Schoster, A., Kokotovic, B., Permin, A., Pedersen, P.D., Bello, F.D., Guardabassi, L. 2013. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Anaerobe, 20(0), 36-41. Shu, Q., Gill, H.S. 2002. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20™) against Escherichia coli O157:H7 infection in mice. FEMS Immunology and Medical Microbiology, 34(1), 59-64. Skjolaas, K.A., Burkey, T.E., Dritz, S.S., Minton, J.E. 2007. Effects of Salmonella enterica serovar Typhimurium, or serovar Choleraesuis, Lactobacillus reuteri and Bacillus licheniformis on chemokine and cytokine expression in the swine jejunal epithelial cell line, IPEC-J2. Veterinary Immunology and Immunopathology, 115(3–4), 299-308. Slater, J.C. 1930. Atomic shielding constants. Physical Review, 36(1), 57. Sreekumar, O., Hosono, A. 2000. Immediate Effect of Lactobacillus acidophilus on the Intestinal Flora and Fecal Enzymes of Rats and the In Vitro Inhibition of Escherichia coli in Coculture. Journal of Dairy Science, 83(5), 931-939. Stober, H., Maier, E., Schmidt, H. 2010. Protective effects of Lactobacilli, Bifidobacteria and Staphylococci on the infection of cultured HT29 cells with different enterohemorrhagic Escherichia coli serotypes are strain-specific. International Journal of Food Microbiology, 144(1), 133-140. Stecchini, M.L., Sarais, I., Bertoldi, M.d. 1991. The influence of Lactobacillus plantarum culture inoculation on the fate of Staphylococcus aureus and Salmonella typhimurium in Montasio cheese. International Journal of Food Microbiology, 14(2), 99-109. Surawicz, C.M. 2003. Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Practice & Research Clinical Gastroenterology, 17(5), 775-783. Tahri, K., Grille, J.P., Schneider, F. 1996. Bifidobacteria Strain Behavior Toward Cholesterol: Coprecipitation with Bile Salts and Assimilation. Current Microbiology, 33(3), 187-193. Tsai, C.-C., Lin, P.-P., Hsieh, Y.-M. 2008. Three Lactobacillus strains from healthy infant stool inhibit enterotoxigenic Escherichia coli grown in vitro. Anaerobe, 14(2), 61-67. Vinderola, G., Matar, C., Perdigon, G. 2007. Milk fermented by Lactobacillus helveticus R389 and its non-bacterial fraction confer enhanced protection against Salmonella enteritidis serovar Typhimurium infection in mice. Immunobiology, 212(2), 107-118. Walling, E., Dols-Lafargue, M., Lonvaud-Funel, A. 2005. Glucose fermentation kinetics and exopolysaccharide production by ropy Pediococcus damnosus IOEB8801. Food Microbiology, 22(1), 71-78. Weibull.com. Issue 95, January 2009. Analysis of Variance. in: Reliability Basics, Weibull.com. Weibull.com. Weiner, R., Langille, S., Quintero, E. 1995. Structure, function and immunochemistry of bacterial exopolysaccharides. Journal of Industrial Microbiology, 15(4), 339-346. Westerdahl, A., Olsson, J.C., Kjelleberg, S., Conway, P.L. 1991. Isolation and characterization of turbot (Scophtalmus maximus)-associated bacteria with inhibitory effects against Vibrio anguillarum. Applied and Environmental Microbiology, 57(8), 2223-2228. Whitfield, C. 1988. Bacterial extracellular polysaccharides. Canadian Journal of Microbiology, 34(4), 415-420. wikimedia. J-Coupling simple multiplets, http://en.m.wikipedia.org/wiki/File:J-Coupling-simple-multiplets.gif. Wikimuzg. D-Glucose shifting into β-D-glucose, https://zh.m.wikipedia.org/wiki/File:Glucose_Fisher_to_Haworth.gif. Zhang, L., Xu, Y.-Q., Liu, H.-Y., Lai, T., Ma, J.-L., Wang, J.-F., Zhu, Y.-H. 2010. Evaluation of Lactobacillus rhamnosus GG using an Escherichia coli K88 model of piglet diarrhoea: Effects on diarrhoea incidence, faecal microflora and immune responses. Veterinary Microbiology, 141(1–2), 142-148. Zhang, Y.-C., Zhang, L.-W., Ma, W., Yi, H.-X., Yang, X., Du, M., Shan, Y.-J., Han, X., Zhang, L.-L. 2012. Screening of probiotic lactobacilli for inhibition of Shigella sonnei and the macromolecules involved in inhibition. Anaerobe, 18(5), 498-503. Zhang, Y., Zhang, L., Du, M., Yi, H., Guo, C., Tuo, Y., Han, X., Li, J., Zhang, L., Yang, L. 2011. Antimicrobial activity against Shigella sonnei and probiotic properties of wild lactobacilli from fermented food. Microbiological Research, 167(1), 27-31. Zoumpopoulou, G., Papadimitriou, K., Polissiou, M.G., Tarantilis, P.A., Tsakalidou, E. 2010. Detection of changes in the cellular composition of Salmonella enterica serovar Typhimurium in the presence of antimicrobial compound(s) of Lactobacillus strains using Fourier transform infrared spectroscopy. International Journal of Food Microbiology, 144(1), 202-207. 全國法規資料庫. May 2006. 健康食品管理法 法務部全國法規資料庫工作小組. 行政院衛生署食品藥物管理局. 880802衛署食字第88037803號公告. 健康食品安全性評估方法 沈競, 王元鳳, 魏新林. 2012. 兩種多醣甲基化方法的比較. 上海師範大學學報 (自然科學版), 2, 010. 陳智強. 2004. 培養條件對乳酸菌胞外多醣生產及抗氧化性之影響, 台灣大學. 台灣大學食品科技研究所碩士論文. 喬梁, 塗光中. 2009.1. NMR 核磁共振. 化學工業出版社 生物‧醫藥出版分社, 北京. 黃美瑩. 2006. 乳酸菌之保健功效. 水產專訊, 7, 43-45. 葉怡成. 2009. 高等實驗計畫法. 五南文化事業, 五南文化事業. 葉恭誌. 2007. Lactobacillus paracasei 33益生菌優酪乳在塵蟎致敏小鼠模式中的抗敏作用, 成功大學. 成功大學微生物及免疫學研究所碩士論文. 蕭如吟. 2002. 利用單獨及混合乳酸菌試製羊奶酸凝酪之研究, 東海大學. 東海大學食品科學系碩士論文.
摘要: 本研究係採用嗜酸乳桿菌(Lactobacillus acidophilus BCRC 10695)作為評估乳酸菌生產胞外多醣體(Exopolysaccharides, EPS)之菌株。論文分三階段依序探討醱酵程序、多醣體純化和多醣體分子結構鑑定。在碳、氮源種類對乳酸菌生產胞外多醣體之影響上,實驗結果顯示蔗糖可獲得較大的胞外多醣體產量。在氮源的選擇方面,實驗結果表示酵母萃取物可獲得較佳的胞外多醣產量。在EPS分子量分布上,不同碳、氮源胞外多醣體皆有相同的分子量分布,其中高分子量EPS占全部EPS的45%。透過添加界面活性劑有助於提升EPS高分子量比率到60-68%。另外探討不同碳、氮源濃度和界面活性劑對乳酸菌生產EPS之最適化產量條件,結果發現當蔗糖濃度、酵母萃取物濃度和polysorbate 80分別為10.15 g/L、25.0 g/L和2.0 g/L時,培養條件為35℃及96小時,可獲得最佳之EPS理論值(923.7 mg/L),與實驗結果923.6 mg/L非常一致。 在EPS之純化及鑑定上,研究結果顯示調整無菌醱酵液酸鹼值到pH 3,經酒精沉澱可獲得最低的蛋白質對多醣體比值。經酒精沉澱純化多醣體水溶液,再調整pH小於1,可移除蛋白質99.9 %及EPS 53.5 %。活性碳等溫吸附實驗結果顯示,溶液中核酸可減少98.5%。Langmuir等溫吸附曲線預測活性碳最大的吸附能力為250.3 OD260/mL/g。添加QIAGEN protease進行醱酵液中蛋白質水解,實驗結果顯示,在經過活性碳吸附後的樣品組和控制組EPS濃度相同。EPS結構鑑定研究,以HPAEC-PAD分析顯示多醣組成之單醣成份有甘露糖、葡萄糖、半乳糖和核糖。GC-MS結構鑑定分析醣類連接位置,結果顯示部份甲基化醣醇乙酸酯2,3,4,6-tetra-O-methyl-D-Glucitol、1,3,4-tri-O-methyl-, triacetate, D-Mannitol、2,3,4-tri-O-methyl-, triacetate, D-Galactitol、2,3-O- methyl-, triacetate, D-ribitol和4-O-methyl-, pentaacetate, D-Glucitol,醣類連接位置組成分別為t-linked D-Glcp、1,2-linked D-Manp、1,6-linked D-Galp、1,5-linked D-Ribf和1,2,3,6-linked D-Glcp。綜合上述生產製造、分離純化和醣類分子結構鑑定之研究成果有助於提升乳酸菌生產EPS,並可應用於生物醫學研究和生物科技產業生產、製造和開發相關醫學級產物。
In this study, fermentation process, purification and identification of extracellular poly-saccharides (Exopolysaccharides, EPSs) from Lactobacillus acidophilus BCRC 10695 were developed. The effect of carbon sources including glucose, fructose, lactose and sucrose was explored. The submerged culture of L. acidophilus was carried out in a 250 mL shake flask at 35 ℃, 50 rpm and initial pH 6.5 under anaerobic cultivation (flushing nitrogen gas) for 55 h. Biomass, pH, sugar consumption and EPS concentration were sampled and analyzed. Effect of nitrogen sources such as proteose peptone no.3, beef extract and yeast extract were ex-plored. Surfactants including polysorbate 20, polysorbate 80 and span 80 were also investi-gated. It was found that yeast extract and sucrose were the best choices for producing EPS by L. acidophilus. The addition of surfactants effectively promoted 15% to higher molecular weight EPSs. Response surface methodology (RSM) was applied for optimization of cultiva-tion conditions. The optimal concentrations of sucrose, yeast extract and polysorbate 80 were 10.15 g/L, 25 g/L and 2 g/L at 96 h respectively. The best predicted EPS production was 923.7 mg/L, similar to that in the experiment of 923.6 mg/L. EPS purification was carried out. The harvested broth adjusted pH to 3 displayed the lowest proteins to EPSs ratio (P/E). The collected EPSs further underwent a pH adjustment to less than 1 followed by centrifugation. The protein and EPS amounts could be removed to 99.9 % and 53.5 % respectively. Activated carbon was used to remove 98.5% of nucleic acid. The addition of QIAGEN protease displayed little effect on EPS purification. Chemical structure of the purified EPS was integratedly identified with HPAEC-PAD, GC-MS and HAPEC-PAD. Analysis results showed four sugars including mannose, glucose, galactose and ribose existed. GC-MS analysis results showed that methylation analysis of EPS had 2,3,4,6-tetra-O-methyl-D-Glucitol; 1,3,4-tri-O-methyl-, triacetate D-Mannitol; 2,3,4-tri-O-methyl-, triacetate, D-Galactitol; 2,3-O-methyl-, triacetate, D-ribitol and 4-O-methyl-, pentaacetate, D-Glucitol of partially O-methylated alditol acetates. The sugar linked location was t-linked D-Glcp, 1,2-linked D-Manp, 1,6-linked D-Galp, 1,5-linked D-Ribf, and 1,2,3,6-linked D-Glcp, respectively. The study results about EPS productiron, pu-rification and chemical structrue identification can be appled to the production of the related medical grade products in the biomedical and biotechnologic industry.
URI: http://hdl.handle.net/11455/3082
其他識別: U0005-0608201323254500
文章連結: http://www.airitilibrary.com/Publication/alDetailedMesh1?DocID=U0005-0608201323254500
Appears in Collections:化學工程學系所

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.